Intervention Review

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

  1. Janine Hartweg1,*,
  2. Rafael Perera1,
  3. Victor M Montori2,
  4. Sean F Dinneen3,
  5. Andrew HAWN Neil1,
  6. Andrew J Farmer4

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 23 JAN 2008

Assessed as up-to-date: 3 APR 2007

DOI: 10.1002/14651858.CD003205.pub2


How to Cite

Hartweg J, Perera R, Montori VM, Dinneen SF, Neil AHAWN, Farmer AJ. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003205. DOI: 10.1002/14651858.CD003205.pub2.

Author Information

  1. 1

    University of Oxford, Department of Primary Health Care, Oxford, UK

  2. 2

    Mayo Clinic, Division of Endocrinology, Department of Internal Medicine, Rochester, MN, USA

  3. 3

    University College Hospital, Galway, Ireland

  4. 4

    The Health Centre, Thame, Oxfordshire, UK

*Janine Hartweg, Department of Primary Health Care, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK. janine.hartweg@green.oxford.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008

SEARCH

  1. Current Version

    Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

    Janine Hartweg, Rafael Perera, Victor M Montori, Sean F Dinneen, Andrew HAWN Neil and Andrew J Farmer

    Version of Record online: 23 JAN 2008 | DOI: 10.1002/14651858.CD003205.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Fish oil in people with type 2 diabetes mellitus

    A Farmer, V Montori, S Dinneen and C Clar

    Version of Record online: 23 JUL 2001 | DOI: 10.1002/14651858.CD003205